PersonalAIze And RenovaroCube Announce A Strategic Partnership To Develop, Validate, And Commercialize Cube's AI-Driven Platform For Early Detection Of Cancer And Other Diseases
PersonalAIze And RenovaroCube Announce A Strategic Partnership To Develop, Validate, And Commercialize Cube's AI-Driven Platform For Early Detection Of Cancer And Other Diseases
PersonalAIze和RenovaroCube宣佈戰略合作，共同開發、驗證並商業化RenovaroCube的人工智能驅動平台，用於早期檢測癌症和其他疾病。
(NASDAQ:RENB) PersonalAIze and RenovaroCube are proud to announce a strategic partnership to develop, validate, and commercialize Cube's AI-driven, multi-omic platform for early detection of cancer and other diseases. This strategic partnership aims to provide services to many AI companies and healthcare systems while also creating the next generation of medical diagnostics through cutting-edge AI by driving greater accuracy, transparency, and trust in healthcare solutions.
(納斯達克：RENB) PersonalAIze和RenovaroCube自豪地宣佈建立戰略合作伙伴關係，共同開發、驗證和商業化Cube的基於人工智能的多組學平台，用於早期癌症和其他疾病的檢測。這一戰略合作伙伴關係旨在爲許多人工智能公司和醫療系統提供服務，同時通過先進的人工智能技術推動醫療診斷的下一代，實現更高的準確性、透明度和信任。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間